Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Unknown 4Recruiting 3Terminated 2Completed 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2Genitourinary 1

Conditions

Prostatic Neoplasms 1Ovarian Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Cardiovascular Diseases 1

Interventions

pembrolizumab 550Specimen Handling 462Carboplatin 441Magnetic Resonance Spectroscopy 429Cyclophosphamide 412Cisplatin 398Radiotherapy 313Gemcitabine 310Bevacizumab 306Paclitaxel 294Biopsy 259Drug Therapy 248Capecitabine 241Oxaliplatin 239fludarabine 238Nivolumab 224venetoclax 219Injections 213Docetaxel 205Fluorouracil 202Dexamethasone 186Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 145durvalumab 143Leucovorin 138atezolizumab 137toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Interventional × Hydroxymethylglutaryl-CoA Reductase Inhibitors × Clear all
NCT06102863 2025-04-29

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Peking University People's Hospital

Phase 2 Recruiting
38 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT03127631 2025-01-31

RADICALPC

McMaster University

Phase NA Recruiting
6,000 enrolled
Genitourinary

Cardiovascular Diseases, Prostatic Neoplasms

NCT06468254 2024-06-21

An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer

Anhui Provincial Cancer Hospital

Phase 2 Recruiting
500 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡